Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus

Citation: Jumar A, Harazny JM, Ott C, Friedrich S, Kistner I, Striepe K, et al. (2016) Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus. PLoS ONE 11(12): e0162608. doi:10.1371/journal.pone.0162608
Published: December 9, 2016

Purpose: In diabetes mellitus type 2, capillary rarefaction plays a pivotal role in the pathogenesis of end-organ damage. We investigated retinal capillary density in patients with early disease.
Methods: This cross-sectional study compares retinal capillary rarefaction determined by intercapillary distance (ICD) and capillary area (CapA), measured non-invasively and in vivo by scanning laser Doppler flowmetry, in 73 patients with type 2 diabetes, 55 healthy controls and 134 individuals with hypertension stage 1 or 2.
Results: In diabetic patients, ICD was greater (23.2±5.5 vs 20.2±4.2, p = 0.013) and CapA smaller (1592±595 vs 1821±652, p = 0.019) than in healthy controls after adjustment for differences in cardiovascular risk factors between the groups. Compared to hypertensive patients, diabetic individuals showed no difference in ICD (23.1±5.8, p = 0.781) and CapA (1556±649, p = 0.768).
Conclusion: In the early stage of diabetes type 2, patients showed capillary rarefaction compared to healthy individuals.


Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Diabetes, Diabetes Featured 2, Ophthalmology and tagged , , .

Post a Comment

You must be logged in to post a comment.